Amgen Inc. v. New York

Supreme Court

Amgen Inc. v. New York

565 U.S. 1103

CourtSupreme Court of the United States

DecidedDecember 27, 2011

DocketNo. 11-363

StatusPublished

This text of 565 U.S. 1103 (Amgen Inc. v. New York) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Amgen Inc. v. New York, 565 U.S. 1103 (2011).

Pincite

Opinion

D. C. W. D. Tex. [Probable jurisdiction noted, ante, p. 1090.] Motion of the Solicitor General for enlargment of time for oral argument, for leave to participate in oral argument as amicus curiae, and for divided argument granted. Time is to be divided as follows: 30 minutes for the appellants, 30 minutes for the appellees, and 10 minutes for the Solicitor General as amicus curiae. Motion of appellees Wendy Davis et al. for divided argument denied.

Free access — add to your briefcase to read the full text and ask questions with AI

D. C. W. D. Tex. [Probable jurisdiction noted, ante, p. 1090.] Motion of the Solicitor General for enlargment of time for oral argument, for leave to participate in oral argument as amicus curiae, and for divided argument granted. Time is to be divided as follows: 30 minutes for the appellants, 30 minutes for the appellees, and 10 minutes for the Solicitor General as amicus curiae. Motion of appellees Wendy Davis et al. for divided argument denied.

Cite This Page — Counsel Stack

Bluebook (online)

565 U.S. 1103, Counsel Stack Legal Research, https://law.counselstack.com/opinion/amgen-inc-v-new-york-scotus-2011.